Pharma

Jul 30, 2015 at 22:39 | Source: PTI
India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.
Jul 30, 2015 at 22:08 | Source: PTI
Glenmark Pharmaceuticals on Thursday posted 3.29 percent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets.
Jul 30, 2015 at 16:41 | Source: Moneycontrol.com
The Nifty closed July series below the 8450 level. The 50-share index was at 8421.80, up 46.75 points or 0.6 percent. The Sensex gained 141.92 points or 0.5 percent at 27705.35.
Jul 30, 2015 at 14:21 | Source: Moneycontrol.com
Total income, during the quarter, rose to Rs 3,758 crore up 7 percent from Rs 3,517.5 crore year-on-year. It earned forex gain of Rs 1.2 crore in Q1FY16 against Rs 47.6 crore (Y-o-Y).
Jul 30, 2015 at 14:00 | Source: Moneycontrol.com
Dr Reddy's Labs was up 6 percent while Cipla, ITC, HDFC and HUL were gainers. Sun Pharma, Hindalco, TCS and Infosys were laggards.
Jul 30, 2015 at 13:35 | Source: CNBC-TV18
Anish Damania, head-Institutional Equities at IDFC Securities has a bullish view on Infosys and feels that one can buy pharma stocks on weakness.
Jul 30, 2015 at 13:00 | Source: Moneycontrol.com
Cipla, HUL, HDFC, ITC and SBI are top gainers on the Sensex. On the losing side are Sun Pharma, TCS, Coal India, Infosys and Tata Steel.
Jul 30, 2015 at 12:26 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends exiting Sun Pharmaceutical Industries as the stock may remain volatile.
Jul 30, 2015 at 11:56 | Source: CNBC-TV18
IDFC Securities is positive on autos, consumer space, oil & gas, IT, private banks and pharma and negative on metals and cement, says Anish Damania, Head-Institutional Equities.
Jul 30, 2015 at 11:29 | Source: Moneycontrol.com
Cipla, HUL, HDFC, Hero Motocorp and NTPC are top gainers while Sun Pharma, TCS and Coal India are among losers in the Sensex.
Messages on Pharma »

subs74

Silver Member

4 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th 2014

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th 2014

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th 2014

jagoinvesto
r

Platinum Member

123 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th 2014

JPInvestor

New Member

1 Followers

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

shmarketgen
ius

Platinum Member

684 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th 2014

countryman

Platinum Member

887 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th 2014

News across the web »
Jul 28, 2015 at 02:15 | Source: FirstPost
Jul 28, 2015 at 00:45 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.